Alcázar Navarrete, Bernardino
Boucot, Isabelle
Naya, Ian
Tombs, Lee
Lipson, David A.
Compton, Chris
Sousa, Ana R.
Feldman, Gregory
Clinical trials referenced in this document:
Documents that mention this clinical trial
Umeclidinium/Vilanterol Versus Tiotropium/Olodaterol in Maintenance-Naïve Patients with Moderate Symptomatic Chronic Obstructive Pulmonary Disease: A Post Hoc Analysis
https://doi.org/10.1007/s41030-018-0057-7
P275 Comparing clinically relevant improvement with umeclidinium/vilanterol and tiotropium/olodaterol in symptomatic copd: a randomised non-inferiority crossover trial
https://doi.org/10.1136/thoraxjnl-2017-210983.417
P275 Comparing clinically relevant improvement with umeclidinium/vilanterol and tiotropium/olodaterol in symptomatic copd: a randomised non-inferiority crossover trial
https://doi.org/10.1136/thoraxjnl-2017-210983.473
Funding for this research was provided by:
GSK
Article History
Received: 16 April 2018
First Online: 20 June 2018